课题基金 / 基金详情

项目摘要

项目成果

Charles M. Stein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Specific Aims of the Vanderbilt University Multidisciplinary Clinical Research Center (VMCRC) are: 1) To pursue a multidisciplinary clinical research scientific program that will alter the outcomes of patients with rheumatic diseases. 2) To promote and foster multidisciplinary clinical research in rheumatic diseases by leveraging institutional training and research resources and the extensive research base that supports the VMCRC and facilitate growth of new projects and the training of new investigators. The VMCRC (Director: C. Michael Stein MD; Associate Director: Wayne Ray PhD) is comprised of three clinical research projects centered around a Methodology Core that serves all projects. The three projects span a range of clinical research approaches (CRC clinical research, pharmacoepidemiology, health outcomes) and diverse rheumatic diseases (rheumatoid arthritis, lupus, osteoarthritis) central to the mission of NIAMS. Project 1 (Stein) is a clinical research/CRC proof-of-concept study using pioglitazone to define the relationships between hyperinsulinemia, disease activity and inflammation in patients with rheumatoid arthritis. Project 2 (Griffin) studies the effect of newer disease modifying anti-rheumatic drugs on the long-term outcomes of cardiovascular disease, diabetes, infection and lymphoma. Project 3 (Cooper) uses a unique local pharmaco-epidemiologic resources to address the risks of anti-rheumatic drugs administered during pregnancy. A common Methodology Core (Arbogast) provides support for the design, collection and analysis of data, and the development of new techniques for improvement of the research methodology used. An Executive Committee and an External Advisory Committee will assist in scientific direction, strategic planning and the leveraging of VMCRC and institutional resources to greatest effect. An Administrative Unit will ensure responsible, efficient conduct of research, seamless communication, fiscal efficiency and thoughtful prioritization of resources. In summary, the VMCRC brings together talented multidisciplinary clinical researchers with a track record in performing collaborative research, fostering new research and facilitating the growth of trainees. The VMCRC is situated in an environment that provides an extraordinarily rich research base as well as outstanding institutional resources and a commitment to clinical research that will facilitate success of the Center.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s13104-015-1185-x
发表时间: 2015-07-04
期刊: BMC research notes
影响因子: 1.8
作者: [Chung, Cecilia P, Callahan, S Todd, Ray, Wayne A]
通讯作者: Ray, Wayne A
DOI: 10.1097/bor.0b013e328356d212
发表时间: 2012-09
期刊: Current opinion in rheumatology
影响因子: 5.1
作者: [Kawai VK, Stein CM, Perrien DS, Griffin MR]
通讯作者: Griffin MR
Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission.
坚持使用缓解疾病的抗风湿药物以及暴露错误分类对入院风险的影响。
DOI: 10.1002/acr.20087
发表时间: 2010
期刊: Arthritis care & research
影响因子: 4.7
作者: [Grijalva,CarlosG, Kaltenbach,Lisa, Arbogast,PatrickG, MitchelJr,EdwardF, Griffin,MarieR]
通讯作者: Griffin,MarieR
DOI: 10.1002/art.39462
发表时间: 2016-02
期刊: Arthritis & rheumatology (Hoboken, N.J.)
影响因子: --
作者: [Wiese AD, Griffin MR, Stein CM, Mitchel EF Jr, Grijalva CG]
通讯作者: Grijalva CG
7
    Pharmacogenetics to improve drug therapy
    Pharmacogenetics to improve drug therapy
    Drug Metabolism Genotypes in Clinical Practice
    • 批准号:
      8788543
    • 项目类别:
    • 资助金额:
      $28.26万
    • 财政年份:
      2014
    • 负责人:
      Charles M. Stein
    • 依托单位:
    Drug Metabolism Genotypes in Clinical Practice
    海外基金